Summit Securities Group’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-523
Closed -$9.07K 937
2024
Q4
$9.07K Buy
+523
New +$10K ﹤0.01% 470
2015
Q1
Sell
-100
Closed -$1K 516
2014
Q4
$1K Hold
100
﹤0.01% 559
2014
Q3
$2K Buy
+100
New +$2.3K ﹤0.01% 609
2013
Q3
Sell
-1,737
Closed -$54K 482
2013
Q2
$54K Buy
+1,737
New +$46.6K 0.03% 179

Other funds holding INVA

Summit Securities Group's INVA Position: Q1 2025 in Review

Summit Securities Group sold out of Innoviva (INVA) in Q1 2025, closing a stake of 523 shares — an estimated $9.07K sold.

Summit Securities Group first reported a position in INVA in Q2 2013 and held it in 4 quarters. The position peaked at $54K in Q2 2013. 246 funds tracked by Wall St. Rank hold INVA as of Q1 2025.

  • Summit Securities Group reported no remaining Innoviva position as of Q1 2025 after selling out during the quarter.
  • Summit Securities Group sold 523 Innoviva shares in Q1 2025, an estimated $9.07K.
  • Summit Securities Group first reported a position in Innoviva in Q2 2013 and held it in 4 quarters.
  • Summit Securities Group's Innoviva position peaked at $54K in Q2 2013.
  • 246 funds tracked by Wall St. Rank held Innoviva as of Q1 2025.

Based on Summit Securities Group's 13F filing for Q1 2025, filed 13 May 2025.